Anti-inflammatory effects of egg white combined with chalcanthite in lipopolysaccharide-stimulated BV2 microglia through the inhibition of NF-κB, MAPK and PI3K/Akt signaling pathways

Choi,Eun A; Park,Hye  Young; Yoo,Hwa-Seung; Choi,Yung  Hyun

doi:10.3892/ijmm.2012.1169

Anti-inflammatory effects of egg white combined with chalcanthite in lipopolysaccharide-stimulated BV2 microglia through the inhibition of NF-κB, MAPK and PI3K/Akt signaling pathways

Authors:
- Eun A Choi
- Hye Young Park
- Hwa-Seung Yoo
- Yung Hyun Choi
View Affiliations

Affiliations: Insan Bamboo Salt Inc. and Insan Korean Medical Cancer Clinic, Hamyang 676-805, Republic of Korea, Department of Pharmacy, Busan National University, Busan 609-735, Republic of Korea, Department of East-West Cancer Center, College of Oriental Medicine, Daejeon University, Daejeon 301-724, Republic of Korea, Department of Biochemistry, Dongeui University College of Oriental Medicine, Busan 614-052, Republic of Korea
Published online on: November 1, 2012 https://doi.org/10.3892/ijmm.2012.1169
Pages: 154-162

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Egg white-chalcanthite (EWCC) is a mixture of egg white and chalcanthite prepared by roasting chalcanthite (which is a natural mineral mainly composed of CuSO4•5H2O) to the point of dehydration, pulverizing the dehydrated chalcanthite and then mixing the pulverized chalcanthite to react with egg white to trigger a reaction. When egg white-chalcanthite is prepared in this manner, the toxicity of chalcanthite is neutralized by the egg white, so that the toxicity is reduced or removed and the pharmaceutical properties are increased. However, the cellular and molecular mechanisms underlying the pharmacological activity of EWCC remain poorly understood. In this study, we investigated the inhibitory effects of EWCC on the production of lipopolysaccharide (LPS)-induced pro-inflammatory mediators in BV2 microglia. Our data indicated that the EWCC treatment significantly inhibited the excessive production of nitric oxide and prostaglandin E2 in LPS-stimulated BV2 microglia in a concentration-dependent manner without causing cytotoxicity. It also attenuated the expression of inducible nitric oxide synthase, cyclooxygenase-2 and pro-inflammatory cytokines, including interleukin-1β and tumor necrosis factor-α. Moreover, EWCC exhibited anti-inflammatory properties by the suppression of nuclear factor‑κB (NF-κB) activation by blocking IκB-α degradation, downregulation of extracellular signal-regulated kinase, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/Akt pathways. Our results indicate that the inhibitory effects of EWCC on LPS-stimulated inflammatory mediator production in BV2 microglia are associated with the suppression of the NF-κB, MAPK and PI3K/Akt signaling pathways. These findings suggest that EWCC may offer a substantial therapeutic potential for the treatment of neurodegenerative diseases that are accompanied by microglial activation.

View Figures

View References

1	Bielory L, Chiaramonte L, Ehrlich P and Field J: Alternative treatment for allergy and asthma. J Asthma. 40(Suppl): S47–S53. 2003.
2	Enrico P, Sirca D and Mereu M: Antioxidants, minerals, vitamins, and herbal remedies in tinnitus therapy. Prog Brain Res. 166:323–330. 2007. View Article : Google Scholar : PubMed/NCBI
3	Olaku O and White JD: Herbal therapy use by cancer patients: a literature review on case reports. Eur J Cancer. 47:508–514. 2011. View Article : Google Scholar : PubMed/NCBI
4	Nordstrom DK and Alpers CN: Negative pH, efflorescent mineralogy, and consequences for environmental restoration at the Iron Mountain Superfund site, California. Proc Natl Acad Sci USA. 96:3455–3462. 1999. View Article : Google Scholar : PubMed/NCBI
5	Latshaw JD and Osman M: Distribution of selenium in egg white and yolk after feeding natural and synthetic selenium compounds. Poult Sci. 54:1244–1252. 1975. View Article : Google Scholar : PubMed/NCBI
6	White HB III: Vitamin-binding proteins in the nutrition of the avian embryo. J Exp Zool (Suppl). 1:53–63. 1987.PubMed/NCBI
7	Stevens L: Egg white proteins. Comp Biochem Physiol B. 100:1–9. 1991.
8	Jacobs K, Shen L, Benemariya H and Deelstra H: Selenium distribution in egg white proteins. Z Lebensm Unters Forsch. 196:236–238. 1993. View Article : Google Scholar : PubMed/NCBI
9	Yamasaki K, Kajimura K, Nakano M, Yokoyama H, Yoneda K and Umezawa C: Effects of preparations of Chinese medicinal prescriptions on digestive enzymes in vitro and in vivo. Biol Pharm Bull. 21:133–139. 1998. View Article : Google Scholar : PubMed/NCBI
10	Choi EA, Kim KH, Yoo BC and Yoo HS: Induction of apoptotic cell death by egg white combined-chalcanthite on NCI-H460 human lung cancer cells. J Korean Pharmacopuncture Inst. 12:49–59. 2009.(In Korean).
11	Perry VH and Gordon S: Macrophages and microglia in the nervous system. Trends Neurosci. 11:273–277. 1988. View Article : Google Scholar : PubMed/NCBI
12	Zielasek J and Hartung HP: Molecular mechanisms of microglial activation. Adv Neuroimmunol. 6:191–222. 1996. View Article : Google Scholar
13	Block ML, Zecca L and Hong JS: Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 8:57–69. 2007. View Article : Google Scholar : PubMed/NCBI
14	Rankine EL, Hughes PM, Botham MS, Perry VH and Felton LM: Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment. Eur J Neurosci. 24:77–86. 2006. View Article : Google Scholar : PubMed/NCBI
15	Lynch MA: The multifaceted profile of activated microglia. Mol Neurobiol. 40:139–156. 2009. View Article : Google Scholar : PubMed/NCBI
16	Gonzalez-Scarano F and Baltuch G: Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci. 22:219–240. 1999. View Article : Google Scholar : PubMed/NCBI
17	Wirenfeldt M, Ladeby R, Dalmau I, Banati RB and Finsen B: Microglia - biology and relevance to disease. Ugeskr Laeger. 167:3025–3030. 2005.(In Danish).
18	Garden GA and Möller T: Microglia biology in health and disease. J Neuroimmune Pharmacol. 1:127–137. 2006. View Article : Google Scholar : PubMed/NCBI
19	Eikelenboom P and van Gool WA: Neuroinflammatory perspectives on the two faces of Alzheimer’s disease. J Neural Transm. 111:281–294. 2004.PubMed/NCBI
20	Gao HM, Liu B, Zhang W and Hong JS: Novel anti-inflammatory therapy for Parkinson’s disease. Trends Pharmacol Sci. 24:395–401. 2003.
21	Liu B and Hong JS: Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther. 304:1–7. 2003. View Article : Google Scholar : PubMed/NCBI
22	Burroughs M, Cabellos C, Prasad S and Tuomanen E: Bacterial components and the pathophysiology of injury to the blood-brain barrier: does cell wall add to the effects of endotoxin in gram-negative meningitis? J Infect Dis. 165(Suppl 1): S82–S85. 1992. View Article : Google Scholar : PubMed/NCBI
23	Jung WK, Lee DY, Park C, Choi YH, Choi I, Park SG, Seo SK, Lee SW, Yea SS, Ahn SC, Lee CM, Park WS, Ko JH and Choi IW: Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases. Br J Pharmacol. 159:1274–1285. 2010. View Article : Google Scholar : PubMed/NCBI
24	Baldwin AS Jr: The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 14:649–683. 1996. View Article : Google Scholar : PubMed/NCBI
25	Lee SJ and Lee S: Toll-like receptors and inflammation in the CNS. Curr Drug Targets Inflamm Allergy. 1:181–191. 2002. View Article : Google Scholar : PubMed/NCBI
26	Harari OA and Liao JK: NF-κB and innate immunity in ischemic stroke. Ann NY Acad Sci. 1207:32–40. 2010.
27	Sarkar FH, Li Y, Wang Z and Kong D: NF-kappaB signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol. 27:293–319. 2008. View Article : Google Scholar : PubMed/NCBI
28	Mankan AK, Lawless MW, Gray SG, Kelleher D and McManus R: NF-kappaB regulation: the nuclear response. J Cell Mol Med. 13:631–643. 2009. View Article : Google Scholar : PubMed/NCBI
29	Lee YH, Jeon SH, Kim SH, Kim C, Lee SJ, Koh D, Lim Y, Ha K and Shin SY: A new synthetic chalcone derivative, 2-hydroxy-3′,5,5′-trimethoxychalcone (DK-139), suppresses the Toll-like receptor 4-mediated inflammatory response through inhibition of the Akt/NF-κB pathway in BV2 microglial cells. Exp Mol Med. 44:369–377. 2012.PubMed/NCBI
30	Lee SH, Kim DW, Back SS, Hwang HS, Park EY, Kang TC, Kwon OS, Park JH, Cho SW, Han KH, Park J, Eum WS and Choi SY: Transduced Tat-Annexin protein suppresses inflammation-associated gene expression in lipopolysaccharide (LPS)-stimulated Raw 264.7 cells. BMB Rep. 44:484–489. 2011. View Article : Google Scholar : PubMed/NCBI
31	Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr and Mayo MW: Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol. 20:1626–1638. 2000. View Article : Google Scholar : PubMed/NCBI
32	Wei J and Feng J: Signaling pathways associated with inflammatory bowel disease. Recent Pat Inflamm Allergy Drug Discov. 4:105–117. 2010. View Article : Google Scholar : PubMed/NCBI
33	Kim SH, Smith CJ and Van Eldik LJ: Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production. Neurobiol Aging. 25:431–439. 2004. View Article : Google Scholar : PubMed/NCBI
34	Zhang Y and Dong C: Regulatory mechanisms of mitogen-activated kinase signaling. Cell Mol Life Sci. 64:2771–2789. 2007. View Article : Google Scholar : PubMed/NCBI
35	Kreutzberg GW: Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:312–318. 1996. View Article : Google Scholar : PubMed/NCBI
36	Ohshima H and Bartsch H: Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mut Res. 305:253–264. 1994. View Article : Google Scholar : PubMed/NCBI
37	Murphy S: Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia. 29:1–13. 2000. View Article : Google Scholar : PubMed/NCBI
38	Zekry D, Epperson TK and Krause KH: A role for NOX NADPH oxidases in Alzheimer’s disease and other types of dementia? IUBMB Life. 55:307–313. 2003.
39	Brown GC and Bal-Price A: Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol. 27:325–355. 2003. View Article : Google Scholar : PubMed/NCBI
40	Minghetti L: Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 63:901–910. 2004.PubMed/NCBI
41	St-Onge M, Flamand N, Biarc J, Picard S, Bouchard L, Dussault AA, Laflamme C, James MJ, Caughey GE, Cleland LG, Borgeat P and Pouliot M: Characterization of prostaglandin E₂ generation through the cyclooxygenase (COX)-2 pathway in human neutrophils. Biochim Biophys Acta. 1771:1235–1245. 2007.
42	Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M and Iadecola C: Prostaglandin E₂ EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med. 12:225–229. 2006.
43	Hewett SJ, Uliasz TF, Vidwans AS and Hewett JA: Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther. 293:417–425. 2000.PubMed/NCBI
44	Moon DO, Choi YH, Kim ND, Park YM and Kim GY: Anti-inflammatory effects of beta-lapachone in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol. 7:506–514. 2007. View Article : Google Scholar : PubMed/NCBI
45	Lee JY, Jhun BS, Oh YT, Lee JH, Choe W, Baik HH, Ha J, Yoon KS, Kim SS and Kang I: Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells. Neurosci Lett. 396:1–6. 2006. View Article : Google Scholar